Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Brindusa Truta"'
Autor:
Brindusa Truta, Ferdouse Begum, Lisa Wu Datta, Steven R. Brant, Judy H. Cho, Richard H. Duerr, Dermot B.P. McGovern, John R. Rioux, Mark S. Silverberg
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 1, Pp 22-32 (2023)
Background and Aims: Inflammatory bowel disease (IBD) is caused by interaction of genetic and environmental risk factors. We evaluated potential determinants of the post-1990 increased incidence in North America. Methods: Using fitted generalized lin
Externí odkaz:
https://doaj.org/article/dd85c3f4ae8a48deb59f327504bffcdd
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 5, Pp 785-791 (2022)
Background and Aims: Adalimumab (ADA) transport across the placenta increases with gestational age advances. We evaluated child–mother health outcomes related to the timing of the last ADA dose before delivery. Methods: Using IBM MarketScan data, w
Externí odkaz:
https://doaj.org/article/1459fd8e8c754ab1aa88e98699c7309c
Autor:
Evangelos Tsipotis, Ankith Maremanda, Laura Bowles Zeiser, Caoilfhionn Connolly, Sowmya Sharma, Sharon Dudley-Brown, Sarah Frey, Mark Lazarev, Joanna M. Melia, Alyssa M. Parian, Dorry L. Segev, Brindusa Truta, Huimin Yu, William A. Werbel, Florin M. Selaru
Publikováno v:
Medicina, Vol 59, Iss 8, p 1487 (2023)
Background: The emergence of new SARS-CoV-2 variants calls for more data on SARS-CoV-2 mRNA vaccine response. Aims: We aimed to assess the response to a third mRNA vaccine dose against SARS-CoV-2 in inflammatory bowel disease (IBD) patients. Methods:
Externí odkaz:
https://doaj.org/article/846236f07bab4217ac3e6fb73de14198
Autor:
Evangelos, Tsipotis, Sarah, Frey, Caoilfhionn, Connolly, William A, Werbel, Reezwana, Chowdhury, Sharon, Dudley-Brown, Joanna M, Melia, Alyssa M, Parian, Brindusa, Truta, Huimin, Yu, Florin M, Selaru, Dorry L, Segev, Mark, Lazarev
Publikováno v:
American Journal of Gastroenterology. 117:798-801
The response to SARS-CoV-2 vaccination of patients with inflammatory bowel disease (IBD) on immune-modifying therapies requires further investigation because previous studies indicate that patients on immune therapy might have decreased antibody conc
Publikováno v:
World Journal of Gastrointestinal Pharmacology and Therapeutics
Background The existence of genetic anticipation has been long disputed in inflammatory bowel disease (IBD) in the absence of the explanatory mechanism. Aim To determine whether it was predictive of genetic anticipation, we evaluated telomere length
Autor:
Brindusa Truta
Publikováno v:
World journal of gastroenterology. 28(13)
Therapeutic drug monitoring (TDM) was one of most sought-after objective tools to determine therapeutic efficiency of different biologics and its role in the management of patients with inflammatory bowel disease (IBD) was regarded with great anticip
Autor:
Sandy H. Fang, Joseph K. Canner, Azah Althumari, Brindusa Truta, Jonathan E. Efron, Bashar Safar, Ira L. Leeds
Publikováno v:
Inflammatory Bowel Diseases. 26:1110-1117
Objectives Early discontinuation of infliximab (IFX) in pregnant women with inflammatory bowel disease (IBD) decreases the intrauterine fetal exposure to the drug but may increase the risk of disease flaring leading to poor pregnancy outcomes. In thi
Autor:
Bashar Safar, Alodia Gabre-Kidan, Sandy H. Fang, Margaret H. Sundel, Brindusa Truta, Jonathan E. Efron, Ira L. Leeds
Publikováno v:
Dis Colon Rectum
Increasing evidence supports immediate colectomy in acute fulminant ulcerative colitis in comparison with ongoing medical management. Prior studies have been limited to inpatient-only administrative data sets or single-institution experiences.The pur
Autor:
Brindusa Truta
Publikováno v:
Current opinion in gastroenterology. 37(4)
Purpose of review Inflammatory bowel disease (IBD) affects women differently than men. This review outlines the current thinking on the impact of IBD, Crohn's disease and ulcerative colitis, on women's health. Recent findings IBD symptoms worsen duri
Autor:
Samantha Harris, Brittany L. Adler, Clifton O. Bingham, Ana Maria Orbai, Ahmet Hoke, Homa Timlin, Lisa Christopher-Stine, Allan C. Gelber, Berna Aravidis, Jemima Albayda, Carlos A. Pardo, Brindusa Truta, Barney J. Stern, Pavan Bhargava, Edward K. Kasper, Kathryn C. Fitzgerald, Michelle Petri, Edward S. Chen, Christopher A. Mecoli, Mark Lazarev, Nisha A. Gilotra, Ami A. Shah, Ellen M. Mowry, Shiv Saidha, Scott D. Newsome, Julie J. Paik, Thomas E. Lloyd, Morgan Douglas, Alan N. Baer, Vinay Chaudhry, Eleni Tiniakou, Michelle Sharp, Elias S. Sotirchos, Arun Venkatesan
Publikováno v:
medRxiv
Background People with autoimmune or inflammatory conditions taking immunomodulatory/suppressive medications may have higher risk of novel coronavirus disease 2019 (COVID-19). Chronic disease care has also changed for many patients, with uncertain do